Renalytix Statistics

Total Valuation

Renalytix has a market cap or net worth of $21.63 million. The enterprise value is $26.35 million.

Market Cap	21.63M
Enterprise Value	26.35M

Important Dates

The last earnings date was Wednesday, May 15, 2024, before market open.

Earnings Date	May 15, 2024
Ex-Dividend Date	n/a

Share Statistics

Renalytix has 85.57 million shares outstanding.

Shares Outstanding	85.57M
Owned by Insiders (%)	4.85%
Owned by Institutions (%)	5.29%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.74
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	11.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.42

Current Ratio	0.42
Quick Ratio	0.35
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-213.60%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$21,775
Profits Per Employee	-$367,510
Employee Count	102
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

In the past 12 months, Renalytix has paid $8,000 in taxes.

Income Tax	8,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.82% in the last 52 weeks. The beta is 2.19, so Renalytix's price volatility has been higher than the market average.

Beta (5Y)	2.19
52-Week Price Change	-91.82%
50-Day Moving Average	0.51
200-Day Moving Average	0.76
Relative Strength Index (RSI)	30.18
Average Volume (20 Days)	405,523

Short Selling Information

Short Interest	236,560
Short Previous Month	464,909
Short % of Shares Out	1.52%
Short % of Float	n/a
Short Ratio (days to cover)	0.76

Income Statement

In the last 12 months, Renalytix had revenue of $2.22 million and -$37.49 million in losses. Loss per share was -$0.78.

Revenue	2.22M
Gross Profit	-35,000
Operating Income	-34.02M
Pretax Income	-37.48M
Net Income	-37.49M
EBITDA	-36.96M
EBIT	-37.48M
Loss Per Share	-$0.78

Full Income Statement

Balance Sheet

The company has $4.70 million in cash and $9.42 million in debt, giving a net cash position of -$4.72 million or -$0.06 per share.

Cash & Cash Equivalents	4.70M
Total Debt	9.42M
Net Cash	-4.72M
Net Cash Per Share	-$0.06
Equity (Book Value)	-11.11M
Book Value Per Share	-0.13
Working Capital	-8.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.92 million and capital expenditures -$3,000, giving a free cash flow of -$30.92 million.

Operating Cash Flow	-30.92M
Capital Expenditures	-3,000
Free Cash Flow	-30.92M
FCF Per Share	-$0.63

Full Cash Flow Statement

Margins

Gross margin is -1.58%, with operating and profit margins of -1,531.61% and -1,687.80%.

Gross Margin	-1.58%
Operating Margin	-1,531.61%
Pretax Margin	-1,687.44%
Profit Margin	-1,687.80%
EBITDA Margin	-1,664.07%
EBIT Margin	-1,687.44%
FCF Margin	-1,392.21%

Dividends & Yields

Renalytix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.14%
Shareholder Yield	-14.14%
Earnings Yield	-173.30%
FCF Yield	-142.95%

Analyst Forecast

The average price target for Renalytix is $5.00, which is 1,877.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	1,877.07%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Renalytix has an Altman Z-Score of -47.06 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-47.06
Piotroski F-Score	3